Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

Revenue projections:

Revenue projections for LALPATHLAB
Revenue projections for LALPATHLAB

LALPATHLAB's revenue is forecasted to dip below last year's figures, raising concerns for investors who are typically wary of declining financial performance. Such drops can directly affect the company's bottom line, potentially leading to a decrease in overall profitability, making investors more cautious in their decisions.

Financial Ratios:

currentRatio 0.000000
forwardPE 47.995907
debtToEquity 7.135000
earningsGrowth 0.242000
revenueGrowth 0.113000
grossMargins 0.579930
operatingMargins 0.235440
trailingEps 61.630000
forwardEps 29.380000

Dr. Lal PathLabs Limited's positive earnings and revenue growth reflect an optimistic outlook for the company's future. The growth in these key areas indicates that Dr. Lal PathLabs Limited is expected to continue expanding its business and boosting its financial performance in the coming periods.
LALPATHLAB's positive gross and operating margins highlight its profitability and operational efficiency. These strong margins demonstrate the company's ability to control costs while generating substantial revenue, contributing to a healthy financial performance.
LALPATHLAB's forward EPS being lower than its trailing EPS indicates that the company's earnings are projected to decrease. This suggests that LALPATHLAB may struggle to maintain profitability at previous levels, potentially affecting its financial outlook.

Price projections:

Price projections for LALPATHLAB
Price projections for LALPATHLAB

LALPATHLAB's price has continuously remained near the lower end of analysts' projections, indicating that it may be facing challenges in meeting market expectations. This trend raises concerns about the company's future growth trajectory.

Insider Transactions:

Insider Transactions for LALPATHLAB
Insider Transactions for LALPATHLAB


There were 56 LALPATHLAB stock sales, with market price at 3086.539276123047.No sell transactions were completed during the period under review.Investors are purchasing LALPATHLAB more frequently than selling it near the current price levels, which might point to a bullish sentiment. This pattern could be interpreted as a favorable outlook for the stock's future.

Recommendation changes over time:

Recommendations trend for LALPATHLAB
Recommendations trend for LALPATHLAB


Analysts have shown a buy bias for LALPATHLAB, signaling it as a strong investment choice. This positive outlook could motivate investors to allocate funds to LALPATHLAB, seeing it as a reliable and potentially profitable option, especially in an environment where the stock market is highly scrutinized.